Effient and Avandia drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Effient (prasugrel hydrochloride) and Avandia (rosiglitazone maleate). Common drug interactions include myocardial infarction among females and myocardial infarction among males.
The phase IV clinical study analyzes what interactions people have when they take Effient and Avandia. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is Effient?
Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.
What is Avandia?
Avandia has active ingredients of rosiglitazone maleate. It is often used in diabetes. eHealthMe is studying from 142,155 Avandia users. Check the latest studies of Avandia.
37 people who take Effient and Avandia together, and have interactions are studied.

What are the common drug interactions of Effient and Avandia, by gender? *:
female:
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Cardiac disorder
- Cardiovascular disorder (heart diseases)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Acute monocytic leukaemia (a type of blood cancer)
- Acute myocardial infarction (acute heart attack)
- Ankylosing spondylitis (type of arthritis affecting the spine)
- Asthenia (weakness)
- Atrophy (wasting away of a part of the body)
- Bone density decreased
male:
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Acute myocardial infarction (acute heart attack)
- Cardiac failure congestive
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Cardiomyopathy (weakening of the heart muscle)
- Cardiovascular disorder (heart diseases)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Coronary artery bypass
- Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
- Dyslipidaemia (abnormal amount of lipids)
What are the common drug interactions of Effient and Avandia, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Acute myocardial infarction (acute heart attack)
40-49:
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
50-59:
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Acute myocardial infarction (acute heart attack)
- Cardiac failure congestive
- Metastases to liver (cancer spreads to liver)
- Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
- Acute monocytic leukaemia (a type of blood cancer)
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
- Ankylosing spondylitis (type of arthritis affecting the spine)
- Asthenia (weakness)
- Atrophy (wasting away of a part of the body)
60+:
- Acute myocardial infarction (acute heart attack)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Hot flush (sudden feelings of heat)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Metastases to liver (cancer spreads to liver)
- Metastases to lymph nodes (cancer spreads to lymph node)
- Pancreatic carcinoma (pancreatic cancer)
- Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Renal failure (kidney dysfunction)
What are the existing conditions these people have? *
- Cardiac Disorder: 2 people, 5.41%
* Approximation only. Some reports may have incomplete information.
Do you take Effient and Avandia?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Effient and Avandia:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Effient:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Avandia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Effient and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Avandia and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on prasugrel hydrochloride and rosiglitazone maleate (the active ingredients of Effient and Avandia, respectively), and Effient and Avandia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Insulin cause Occult Blood Positive? - 5 seconds ago
- Drug interactions of Klor-Con M20 and Donepezil - 12 seconds ago
- Drug interactions of Dimenhydrinate and Azathioprine - 15 seconds ago
- Could Zyrtec cause Intervertebral Disc Degeneration? - 18 seconds ago
- Drug interactions of Savella and Methotrexate Sodium - 20 seconds ago
- Pentasa vs. Metronidazole, side effect and effectiveness comparison - 31 seconds ago
- Myasthenia Gravis and Urinary Incontinence - 36 seconds ago
- Drug interactions of Droperidol and Feldene - 37 seconds ago
- Relapsing-Remitting Multiple Sclerosis and Bone Loss - 40 seconds ago
- Drug interactions of Sandostatin and Bupropion Hydrochloride - 44 seconds ago